Oncotarget

Advance Online Publications

January 1, 2021

Dear Authors,

The articles in Advanced Publications have been copyedited and incorporate the authors' final corrections. Please cite the articles using the format: authors, title, journal, year, DOI.

Please note: Advance online publications scheduled to be included in an upcoming issue may not be available during pagination. If your article is currently not available for viewing, please check back after 12:00 PM Eastern Time.

With all respect,
Oncotarget team


Editorial

Future directions for immunotherapy in meningioma treatment

Future directions for immunotherapy in meningioma treatment

https://doi.org/10.18632/oncotarget.27994

John W. Rutland, Jonathan T. Dullea,  and Raj K. Shrivastava
PDF  |  How to cite  |  Order a Reprint

Interferon-γ/IRF-1 pathway regulatory mechanisms of PD-L1 expression and relevance for immune checkpoint blockade in hepatocellular carcinoma (HCC)

Interferon-γ/IRF-1 pathway regulatory mechanisms of PD-L1 expression and relevance for immune checkpoint blockade in hepatocellular carcinoma (HCC)

https://doi.org/10.18632/oncotarget.27995

Yihe Yan, Leting Zheng, Qiang Du,  and David A. Geller
PDF  |  How to cite  |  Order a Reprint

Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer

Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer

https://doi.org/10.18632/oncotarget.27998

Anne E. O’Shea, Guy T. Clifton,  and George E. Peoples
PDF  |  How to cite  |  Order a Reprint

Undetected Barrett’s esophagus: how do we improve early detection?

Undetected Barrett’s esophagus: how do we improve early detection?

https://doi.org/10.18632/oncotarget.28005

Holli A. Loomans-Kropp,  and Ellen Richmond
PDF  |  How to cite  |  Order a Reprint

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer

https://doi.org/10.18632/oncotarget.28007

Sasagu Kurozumi, Ayaka Katayama, Ken Shirabe, Jun Horiguchi,  and Emad A. Rakha
PDF  |  How to cite  |  Order a Reprint

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas

https://doi.org/10.18632/oncotarget.28018

Andrew Gould, Daniel Zhang, Víctor A. Arrieta, Roger Stupp,  and Adam M. Sonabend
PDF  |  How to cite  |  Order a Reprint

Control of the Mdm2-p53 signal loop by β-arrestin 2: the ins and outs

Control of the Mdm2-p53 signal loop by β-arrestin 2: the ins and outs

https://doi.org/10.18632/oncotarget.28065

Elodie Blondel-Tepaz, Hervé Enslen,  and Mark G.H. Scott
PDF  |  How to cite  |  Order a Reprint

Reviews

Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy

Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy

https://doi.org/10.18632/oncotarget.28091

Ana Chor, Maria Adriana Skeff, Christina Takiya, Raquel Gonçalves, Marcos Dias, Marcos Farina, Leonardo R. Andrade,  and Valeria de Mello Coelho
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Perspectives

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.28077

Arvin Medhat, Alla Arzumanyan,  and Mark A. Feitelson
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects

Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects

https://doi.org/10.18632/oncotarget.28088

Yuri Lazebnik
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Recent Research Papers

Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis

Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis

https://doi.org/10.18632/oncotarget.28084

Jessica I. Christian, Agnieszka Pastula, Andreas Herbst, Jens Neumann, Maximilian K. Marschall, Andrea Ofner, Heike Zierahn, Marlon R. Schneider, Eckhard Wolf, Michael Quante,  and Frank T. Kolligs
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC